We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.65%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$418M
AUM Growth
-$30.8M
(-6.9%)
Cap. Flow
-$37.5M
Cap. Flow
% of AUM
-8.97%
Top 10 Holdings %
Top 10 Hldgs %
54.35%
Holding
163
New
44
Increased
31
Reduced
48
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$3.75M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$3.59M |
| 3 |
Teck Resources
TECK
|
+$3.58M |
| 4 |
Popular Inc
BPOP
|
+$3.3M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
+$3.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$3.57M |
| 2 |
UGI
UGI
|
+$3.26M |
| 3 |
Universal Health Services
UHS
|
+$3.1M |
| 4 |
Wells Fargo
WFC
|
+$3.08M |
| 5 |
Concrete Pumping Holdings
BBCP
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.06% |
| 2 | Industrials | 7.6% |
| 3 | Materials | 7.59% |
| 4 | Consumer Discretionary | 5.8% |
| 5 | Healthcare | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sanmina
SANM
$10.9B
| $1.12M | 0.27% |
28,782
+6,529
| +29% | +$269K |
|
77
IRIDEX
IRIX
$14.5M
| $1.1M | 0.26% |
156,395
-2,650
| -2% | -$20.1K |
|
|
KRA
78
DELISTED
Kraton Corporation
KRA
| $1.06M | 0.25% |
+32,903
| New | +$1.16M |
|
79
Cooper-Standard Automotive
CPS
$558M
| $1.04M | 0.25% |
+35,828
| New | +$1.11M |
|
80
Sensus Healthcare
SRTS
$50.5M
| $1.03M | 0.25% |
267,900
-20,302
| -7% | -$76.2K |
|
81
Mativ Holdings
MATV
$711M
| $1.02M | 0.24% |
+25,165
| New | +$1.12M |
|
82
Citigroup
C
$226B
| $998K | 0.24% |
14,108
-7,712
| -35% | -$571K |
|
|
CCEC
83
Capital Clean Energy Carriers
CCEC
$1.35B
| $982K | 0.24% |
80,487
-13,524
| -14% | -$166K |
|
84
Comtech Telecommunications
CMTL
$51.8M
| $952K | 0.23% |
+39,405
| New | +$962K |
|
|
FITB
85
Fifth Third Bancorp
FITB
$51.8B
| $918K | 0.22% |
+24,010
| New | +$960K |
|
86
PUT
ARK Web x.0 ETF
ARKW
$1.75B
| $878K | 0.21% |
+5,700
| New | +$817K |
|
87
Array Technologies
ARRY
$855M
| $867K | 0.21% |
+55,595
| New | +$1.17M |
|
88
MetLife
MET
$62.1B
| $822K | 0.2% |
13,739
-17,685
| -56% | -$1.12M |
|
89
Bristow Group
VTOL
$1.36B
| $796K | 0.19% |
+31,086
| New | +$840K |
|
90
BorgWarner
BWA
$13.9B
| $777K | 0.19% |
18,195
-3,208
| -15% | -$141K |
|
|
PMD
91
DELISTED
Psychemedics Corporation
PMD
| $777K | 0.19% |
111,654
-1,113
| -1% | -$7.8K |
|
|
RYZ
92
Ryerson Holding Corp
RYZ
$1.46B
| $760K | 0.18% |
52,073
-72,293
| -58% | -$1.14M |
|
|
PARA
93
DELISTED
Paramount Global Class B
PARA
| $756K | 0.18% |
+16,743
| New | +$691K |
|
94
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
| $740K | 0.18% |
8,000
-118,300
| -94% | -$10.1M |
|
95
Weyco Group
WEYS
$440M
| $706K | 0.17% |
+31,571
| New | +$677K |
|
|
RVI
96
DELISTED
Retail Value Inc. Common Shares
RVI
| $705K | 0.17% |
352,968
+102,364
| +41% | +$182K |
|
97
Northrop Grumman
NOC
$81.2B
| $656K | 0.16% |
1,805
-318
| -15% | -$115K |
|
|
ZVO
98
DELISTED
Zovio Inc. Common Stock
ZVO
| $544K | 0.13% |
+209,828
| New | +$642K |
|
99
Orion Group Holdings
ORN
$418M
| $541K | 0.13% |
94,043
+34,901
| +59% | +$203K |
|
|
USAP
100
DELISTED
Universal Stainless & Alloy
USAP
| $395K | 0.09% |
39,169
-2,842
| -7% | -$28.5K |
|
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Invenomic Capital Management held 163 positions worth $418M, down 6.9% from $448M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Invenomic Capital Management withdrew a net $37.5M in Q2 2021, closing 39 positions and reducing 48 holdings. Its most notable exit was UGI, an estimated $3.26M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 6.9% a quarter earlier, followed by Industrials and Materials.
Against the trend, Invenomic Capital Management opened a new position in Popular Inc worth $3.23M.
- Invenomic Capital Management's largest Q2 2021 buy was Popular Inc: 43,078 shares worth $3.23M.
- Invenomic Capital Management added most to Surgalign Holdings, Inc. Common Stock in Q2 2021, an estimated $3.75M increase.
- Invenomic Capital Management's biggest Q2 2021 reduction was Molson Coors Class B, cutting an estimated $3.57M.
- Invenomic Capital Management fully exited UGI in Q2 2021, selling an estimated $3.26M.
- Invenomic Capital Management's ten largest holdings make up 54% of its $418M portfolio in Q2 2021.
- Invenomic Capital Management opened 44 new positions and closed 39 in Q2 2021.
- Invenomic Capital Management's portfolio value fell 6.9% quarter-over-quarter to $418M.
Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.